Moreover, the critical importance of AKT2 not only in mediating key actions of insulin in health, but also potentially in driving components of the metabolic syndrome such as fatty liver and dyslipidemia in the face of insulin resistance, lends considerable interest to the wider metabolic observations to be made in this rare human “experiment of nature.” This evidence concerns the gene AKT2 and metabolic syndrome.